Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

915 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Therapy of infections in patients with acute leukemia].
Hiddemann W, Maschmeyer G, Link H, Helmerking M, Adam D. Hiddemann W, et al. Med Klin (Munich). 1997 Jul 15;92(7):406-9. doi: 10.1007/BF03042571. Med Klin (Munich). 1997. PMID: 9324625 Review. German.
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy].
Hoelzer D, Gökbuget N, Arnold R, Büchner T, Freund M, Gassmann W, Heil G, Hiddemann W, Löffler H, Lipp T, Ludwig WD, Maschmeyer G, Thiel E, Messerer D. Hoelzer D, et al. Among authors: hiddemann w. Internist (Berl). 1996 Oct;37(10):994-1007. Internist (Berl). 1996. PMID: 9019457 Review. German. No abstract available.
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.
Kern W, Aul C, Maschmeyer G, Kuse R, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Among authors: hiddemann w. Ann Hematol. 1998 Sep;77(3):115-22. doi: 10.1007/s002770050425. Ann Hematol. 1998. PMID: 9797080 Clinical Trial.
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison.
Kern W, Aul C, Maschmeyer G, Schönrock-Nabulsi R, Ludwig WD, Bartholomäus A, Bettelheim P, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Among authors: hiddemann w. Leukemia. 1998 Jul;12(7):1049-55. doi: 10.1038/sj.leu.2401066. Leukemia. 1998. PMID: 9665189 Clinical Trial.
915 results